No Booster Needed
A healthcare worker with an anti-HBs titer of 166 mIU/mL and no known exposure does not need a hepatitis B vaccine booster. This titer is well above the protective threshold and indicates robust immunity that does not require any additional vaccination or monitoring.
Rationale Based on Guidelines
The 2018 ACIP guidelines are unequivocal on this matter 1:
- Persons with anti-HBs concentrations ≥10 mIU/mL after primary vaccination are considered immune
- Immunocompetent persons have long-term protection and do not need further periodic testing to assess anti-HBs levels
- The guidelines explicitly state "No action for hepatitis B prophylaxis" when anti-HBs is ≥10 mIU/mL, regardless of source patient hepatitis B surface antigen status
Your healthcare worker's titer of 166 mIU/mL is more than 16 times the protective threshold of 10 mIU/mL, placing them in a category of excellent immunity.
Understanding the Evidence on Antibody Persistence
Research supports the durability of protection at this titer level:
- A 2021 study demonstrated that healthcare workers with initial titers of 100-999 mIU/mL (which includes your worker's level) maintained protective antibodies for a mean of 25.4 years, with an antibody loss incidence of only 11.3 per 1000 person-years 2
- The same study showed that good responders (≥1000 mIU/mL) had protection lasting up to 31 years, while even moderate responders (100-999 mIU/mL) had excellent long-term protection
Clinical Context: When Action IS Required
To clarify when boosters would be needed, the 2011 ACIP guidelines specify that vaccinated HCP require intervention only in specific exposure scenarios 3:
- With documented immunity (anti-HBs ≥10 mIU/mL): No postexposure prophylaxis, serologic testing, or additional vaccination needed—even after a known HBsAg-positive exposure
- Without documented immunity: Testing and potential intervention required only after an actual exposure event
Important Caveats
Special populations requiring different management:
- Hemodialysis patients need annual anti-HBs testing and boosters when levels fall below 10 mIU/mL 4
- Immunocompromised persons (HIV-positive, chemotherapy recipients, transplant patients) may need annual testing 1
- Healthcare workers without documented post-vaccination titers should have their immunity status assessed at time of hire or exposure, not routinely 1
The key distinction: Your healthcare worker has documented immunity (166 mIU/mL) and no exposure—this is the lowest-risk scenario requiring no action.
Bottom Line
Do nothing. Document the titer of 166 mIU/mL in the worker's occupational health record as proof of immunity. No booster vaccination, no repeat testing, and no additional monitoring is indicated unless this person becomes immunocompromised or goes on hemodialysis in the future.